That said, folks who don't need the absolute best or want to save up for a better solution should find these to be sufficient -- we didn't have a chance to do any in-depth testing and analysis, but expect that to come after we've had a chance to digest all of today's new gadgets.

ENGADGET: Apple EarPods hands-on Mobile

Exclude those patients, and prasugrel looks better, but that analysis was done after the fact, which could raise doubts with the FDA. Lilly is testing a lower dose in those patients going forward.

FORBES: Magazine Article